CDKN1A and esophageal squamous cell carcinoma: Taken together, the results showed that the PI3Kα inhibitor combined with the EZH2 inhibitor synergistically suppressed the proliferation of ESCC cells by transcriptionally activating CDKN1A and inhibiting RB phosphorylation.